Ledger.Open graph →
SEC Form D · filed July 16, 2015

Xalud Therapeutics, Inc

Offering
$7.3M
Sold
$7.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Stephen D. Collins · Lake Forest, ILExec · DirectorSam Eletr · San Francisco, CAExec · DirectorPeter Heinecke · San Francisco, CADirectorLinda Watkins · Boulder, CODirectorRaymond Chavez · Alameda, CAExec · DirectorJohn Forsayeth · San Francisco, CADirectorDavid Kittle · San Diego, CAExec · DirectorPeter Heinecke · San Francisco, CADirectorLinda Watkins · Boulder, CODirectorRaymond Chavez · Alameda, CAExec · DirectorJohn Forsayeth · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Xalud Therapeutics, Inc. — SEC Form D filing (2015) | Ledger